NOX1 and metabolic syndrome: In addition, PDI expression has been shown to be elevated in atherosclerotic lesions [12], while Nox-1 is reported to be upregulated in mesenteric arteries of mice with metabolic syndrome and contributes to vasodilation of these vessels [21].